Nature, Published online: 11 December 2024; doi:10.1038/d41586-024-03855-8
Cancer cells often become unresponsive to multiple types of therapy. It emerges that these ‘cross-resistant’ tumour cells release lipids that reprogram cells called monocytes to stop them from activating tumour-targeting T cells.
source
